Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroacupuncture vs Mirabegron for OAB
NCT03087578Withdrawn
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jul 2017
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoints: Incontinence Impact Questionnaire at Month 3, Overactive Bladder Symptom Score at Month 3 and 4 more. Planned start Jul 2017; status: withdrawn.
Beyond the preview
Go deeper on NCT03087578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03087578.